Effect of intravenous immunoglobulin G on the TNFα-mediated hepatic microvascular inflammatory response

Shock

Volumn 11, Issue 4, 1999, Pages 291-295

  Ito, Yoshiya ^a   Lukita Atmadja, Wahyuni ^a   Machen, Nancy W ^a   Baker, Gregory L ^a   McCuskey, Robert S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL HEPATITIS; ARTICLE; CELL ADHESION; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LEUKOCYTE; LIVER; LIVER CIRCULATION; MALE; METABOLISM; NEUTROPHIL; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; HEPATITIS, ANIMAL; IMMUNOGLOBULIN G; INJECTIONS, INTRAVENOUS; INTERCELLULAR ADHESION MOLECULE-1; KUPFFER CELLS; LEUKOCYTES; LIVER; LIVER CIRCULATION; MALE; NEUTROPHILS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033109177     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199904000-00011     Document Type: Article

References (36)

1. Bone RC: Gram-negative sepsis: A dilemma of modern science. Clin Microbiol Rev 6:57-68, 1993.
2. Parillo JE: Pathogenic mechanisms of septic shock. N Engl J Med 328: 1471-1477, 1993.
3. McCuskey RS: Hepatic microvascular response to endotoxemia and sepsis. Prog Appl Microcirc 19:76-84, 1993.
4. McCuskey RS, McCuskey PA, Urbaschek R, Urbaschek B: Kupffer cell function in host defense. Rev Infect Dis 9:S616-619, 1987.
5. Decker K: Biologically active products of stimulated liver macrophages. Eur J Biochem 192:245-261, 1990.
6. Dwyer JM: Manipulating the immune system with immune globulin. N Engl J Med 326:107-116, 1992.
7. Dominioni L, Diongini R, Zanello M, et al: Effect of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. Arch Surg 126:236-240, 1991.
8. Schedel I, Dreikhausen U, Nentwig B, et al: Treatment of gram-negative septic shock with an immununoglobulin preparation: A prospective, randomized clinical trial. Crit Care Med 19:1104-1113, 1991.
9. Pilz G, Kreuzer E, Kaab S, Appel R, Werdan K: Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. Chest 105:76-82, 1994.
10. Commeta A, Baumgartner J-D, Lee ML, Hanique G, Glauser M-P: Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N Engl J Med 327:234-240, 1992.
11. McCuskey RS, Nishida J, McDonnell D, Baker GL, Urbaschek R, Urbaschek B: Effect of immunogloblin G on the hepatic microvascular inflammatory response during sepsis. Shock 5:28-33, 1996.
12. Mouthon L, Kaveri SV, Spalter SH, et al: Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol 104(Suppl 1):3-9:1996.
13. McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B: Hepatic microvascular responses to tumor necrosis factor. In Wisse E, Knook DL, Decker K (eds): Cells of the Hepatic Sinusoids, II. Leiden, The Netherlands: Kupffer Cell Foundation, 1989, pp 272-276.
14. Schirmer WJ, Schirmer JM, Fry DE: Recombinant human tumor necrosis factor produces hemodynamic changes. Characteristic of sepsis and endotoxemia. Arch Surg 124:445-448, 1989.
15. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
16. Marzi I, Bauer M, Secchi A, Bahrami S, Redl H, Schlag G: Effect of anti-tumor necrosis factor α on leukocyte adhesion in the liver after hemorrhagic shock: An intravital microscopic study in the rat. Shock 3:27-33, 1995.
17. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664, 1987.
18. McCuskey RS: Microscopic methods for studying the microvasculature of internal organs. In Baker CH, Nastuk WF (eds): Physical Techniques in Biology and Medicine Microvascular Technology. New York: Academic Press, 1986, pp247-264.
19. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283-290, 1971.
20. Dijhkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589-599, 1985.
21. Ohira H, Ueno T, Shakado S, et al: Cultured rat hepatic sinusoidal endothelial cells express intercellular adhesion molecule-1 (ICAM-1) by tumor necrosis factor-alpha and interleukin-1 alpha stimulation. J Hepatol 20:729-734, 1994.
22. Essai N, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H: Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 21:1632-1639, 1995.
23. Jaeschke H: Cellular adhesion molecules: Regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol 273 (Gastrointest Liver Physiol 36):G602-G611, 1997.
24. Vollmar B, Glasz J, Menger MD, Messmer K: Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 117:195-200, 1995.
25. Sarphie TG, D'Souza NB, Deaciuc IV: Kupffer cell inactivation prevents lipopolysaccharide-induced structural changes in the rat liver sinusoid: An electron-microscopic study. Hepatology 23:788-796, 1996.
26. Johnson SJ, Hines JE, Burt AD: Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol 166:351-358, 1992.
27. Shimozato T, Iwata M, Tamura N: Suppression of tumor necrosis factor alpha by a human immunoglobulin preparation for intravenous use. Infect Immun 58:1348-1390, 1990.
28. Horiuchi A, Abe Y, Mimyake M, Osuka Y, Kimura S: Natural human IgG inhibits the production of tumor necrosis factor-α and interleukin-1α through the Fc portion. Surg Today 23:241-245, 1993.
29. Baker GL, McCuskey RS: Effects of pooled immunoglobulin (ivIG) on tumor necrosis factor (TNFα) secretion by macrophages. FASEB J 12: A760, 1998.
30. Bendtzen K, Hansen MB, Ross C, Svenson M: Cytokne autoantibodies, in Peter JB, Shoenfeld Y (eds): Autoantibodies. Amsterdam: Elsevier Science, 1996, pp 209-216.
31. Svenson M, Hansen MB, Bendtzen K: Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest 92:2533-2539, 1993.
32. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc Natl Acad Sci USA 89:4845-4849, 1992.
33. Aukrust P, Hestdal K, Lien E, et al: Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-α activity in human immunodeficiency virus type 1 infection. J Infect Dis 176:913-923, 1997.
34. Shimozato T, Iwata M, Tamura N: Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumor necrosis factor alpha and interleulin-1 production. Immunology 72:497-501, 1991.
35. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV: κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med 171:35-47, 1990.
36. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Mariiatis T: Transcriptional regulation of endothelial cell adhesion molecule: NF-κB and cytokine-inducible enhancers. FASEB J 9:899-909, 1995.